KIMBERLY FERN: Open Payments
NPI 1245535749 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$512 in 27 payments from 13 companies in 2025. Trend: 2023 $670 · 2024 $721 · 2025 $512
Food & beverage: $512
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $156 |
| PFIZER INC. | 3 | $61 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $38 |
| Collegium Pharmaceutical, Inc. | 2 | $36 |
| Globus Medical, Inc. | 2 | $36 |
| Lundbeck LLC | 1 | $33 |
| Averitas Pharma Inc. | 1 | $29 |
| Valinor Pharma, LLC | 1 | $21 |
| Amgen Inc. | 1 | $21 |
| Ipsen Biopharmaceuticals, Inc | 1 | $21 |
Products named: QULIPTA, BOTOX, NURTEC ODT, RELISTOR, Senza, VYEPTI, QUTENZA, MOVANTIK.
Industry payments across MD — which companies pay providers there.
